Phospholipids

PRESS RELEASE 05 July 2023: Croda International Plc (‘Croda’) announced that it has acquired Solus BioTech, a global leader in premium, biotechnology-derived...

Abstract Melanoma is the most aggressive form of skin cancer, with increasing incidence and mortality rates. To overcome current treatment...

Recently, cGMP analogues have been investigated for the treatment of inherited retinal degenerations (IRD) using intravitreal injections. However, higher vitreous...

Abstract Sufficient ocular bioavailability is often considered a challenge by the researchers, due to the complex structure of the eye...

Glioblastoma (GB) is one of the most lethal types of neoplasms. Its biologically aggressive nature and the presence of the...

Mangiferin is a herbal drug that has proven anticancer potential. Owing to its lower aqueous solubility and poor oral bioavailability,...

Emerging drug-delivery systems demand a controlled or programmable or sustained release of drug molecules to improve therapeutic efficacy and patient...

Numerous drugs have emerged to treat various diseases, such as COVID-19, cancer, and protect human health. Approximately 40% of them...

Tuberculosis, a predominantly pulmonary pathology, is currently the deadliest infection worldwide. Its treatment is based on combination therapy involving selected...

Lipid vesicles can provide a cost-effective enhancement of skin drug absorption when vesicle production process is optimised. It is an...